CollPlant Biotechnologies (CLGN) Total Debt (2017 - 2019)
CollPlant Biotechnologies (CLGN) posted Total Debt of $24000.0 for Q4 2019, down 99.34% on a QoQ basis from $3.6 million in Q4 2017.
CollPlant Biotechnologies (CLGN) Total Debt (2017 - 2019) Analysis & Trends
CollPlant Biotechnologies' Total Debt history runs 2 years deep, the most recent figure standing at $24000.0 for Q4 2019.
- Quarterly Total Debt changed N/A year-over-year to $24000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $24000.0 (changed N/A YoY) and the FY2019 annual result came in at $24000.0, changed N/A from the prior year.
- Total Debt was $24000.0 for Q4 2019 at CollPlant Biotechnologies, down from $3.6 million in the prior quarter.
- Across five years, Total Debt topped out at $3.6 million in Q4 2017 and bottomed at $24000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 24,000.00 |
| Dec 31, 2017 | 3.65 Mn |